Adenovirus encoding human platelet-derived growth factor-B delivered to alveolar bone defects exhibits safety and biodistribution profiles favorable for clinical use.

Platelet-derived growth factor (PDGF) gene therapy offers promise for tissue engineering of tooth-supporting alveolar bone defects. To date, limited information exists regarding the safety profile and systemic biodistribution of PDGF gene therapy vectors when delivered locally to periodontal osseous defects. The aim of this preclinical study was to determine the safety profile of adenovirus encoding the PDGF-B gene (AdPDGF-B) delivered in a collagen matrix to periodontal lesions. Standardized alveolar bone defects were created in rats, followed by delivery of matrix alone or containing AdPDGF-B at 5.5 x 10(8) or 5.5 x 10(9) plaque-forming units/ml. The regenerative response was confirmed histologically. Gross clinical observations, hematology, and blood chemistries were monitored to evaluate systemic involvement. Bioluminescence and quantitative polymerase chain reaction were used to assess vector biodistribution. No significant histopathological changes were noted during the investigation. Minor alterations in specific hematological and blood chemistries were seen; however, most parameters were within the normal range for all groups. Bioluminescence analysis revealed vector distribution at the axillary lymph nodes during the first 2 weeks with subsequent return to baseline levels. AdPDGF-B was well contained within the localized osseous defect area without viremia or distant organ involvement. These results indicate that AdPDGF-B delivered in a collagen matrix exhibits acceptable safety profiles for possible use in human clinical studies.

[1]  William V Giannobile,et al.  Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. , 2005, Journal of periodontology.

[2]  R. Engler,et al.  Matrix-Enabled Gene Delivery for Tissue Repair , 2010 .

[3]  Johanna Andrae,et al.  Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.

[4]  F. Nishimura,et al.  Comparative Study of the Chemotactic Responses of Periodontal Ligament Cells and Gingival Fibroblasts to Polypeptide Growth Factors , 1996, Journal of dental research.

[5]  Y. M. Lee,et al.  Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. , 2000, Biomaterials.

[6]  T. Eggerman,et al.  Rapid Kupffer cell death after intravenous injection of adenovirus vectors. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  M. Waters,et al.  Growth factor modulation of mitogenic responses and proteoglycan synthesis by human periodontal fibroblasts , 1998, Journal of cellular physiology.

[8]  S. Lynch,et al.  Comparison of canine and non-human primate animal models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. , 1994, Journal of periodontology.

[9]  C. Kawcak,et al.  Delivery of growth factors using gene therapy to enhance bone healing. , 2004, Veterinary surgery : VS.

[10]  J. Fiorellini,et al.  A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. , 1997, Journal of periodontology.

[11]  M. Herlyn,et al.  FGF2-Targeted adenovirus encoding platelet-derived growth factor-B enhances de novo tissue formation. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Jörg Fiedler,et al.  To go or not to go: Migration of human mesenchymal progenitor cells stimulated by isoforms of PDGF , 2004, Journal of cellular biochemistry.

[13]  Q. Jin,et al.  Gene therapeutics for periodontal regenerative medicine. , 2006, Dental clinics of North America.

[14]  P. Ma,et al.  Platelet-Derived Growth Factor Delivery via Nanofibrous Scaffolds for Soft-Tissue Repair. , 2010, Advances in skin & wound care.

[15]  B. Baum,et al.  Gene Therapy: Some History, Applications, Problems, and Prospects , 2008, Toxicologic pathology.

[16]  Yan Jin,et al.  Periodontal tissue engineering and regeneration: current approaches and expanding opportunities. , 2010, Tissue engineering. Part B, Reviews.

[17]  C. Heldin,et al.  Mechanisms of platelet‐derived growth factor–induced chemotaxis , 2001, International journal of cancer.

[18]  E. De Clercq,et al.  Mouse Adenovirus Type 1 Infection in SCID Mice: an Experimental Model for Antiviral Therapy of Systemic Adenovirus Infections , 2005, Antimicrobial Agents and Chemotherapy.

[19]  A. Gaggar,et al.  Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons. , 2005, Human gene therapy.

[20]  L. Chandler,et al.  Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  F. Yuan,et al.  Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery , 2005, British Journal of Cancer.

[22]  B. Baum,et al.  Sorting of transgenic secretory proteins in rhesus macaque parotid glands after adenovirus-mediated gene transfer. , 2008, Human gene therapy.

[23]  N. Tietz,et al.  Laboratory tests in the differential diagnosis of hyperamylasemia. , 1986, Clinical chemistry.

[24]  William V Giannobile,et al.  Adenoviral gene transfer of PDGF downregulates gas gene product PDGFalphaR and prolongs ERK and Akt/PKB activation. , 2002, American journal of physiology. Cell physiology.

[25]  E. Galun,et al.  Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[26]  C. Kiritsy,et al.  Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. , 1996, Journal of periodontal research.

[27]  R. Crystal,et al.  Use of quantitative TaqMan real-time PCR to track the time-dependent distribution of gene transfer vectors in vivo. , 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  Lily Wu,et al.  Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. , 2006, Human gene therapy.

[29]  SISTER M AGNESE,et al.  Amylase. , 1952, Hospital progress.

[30]  James B. Mitchell,et al.  Prevention of irradiation-induced salivary hypofunction by microvessel protection in mouse salivary glands. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  William V Giannobile,et al.  Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. , 2006, Tissue engineering.

[32]  E. Furth,et al.  Gene transfer into the liver of nonhuman primates with E1-deleted recombinant adenoviral vectors: safety of readministration. , 1999, Human gene therapy.

[33]  William V Giannobile,et al.  Growth factor delivery for oral and periodontal tissue engineering , 2006, Expert opinion on drug delivery.

[34]  R. Rutherford,et al.  Gene therapy of bone morphogenetic protein for periodontal tissue engineering. , 2003, Journal of periodontology.

[35]  C. Dinney,et al.  Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse , 1999, Cancer Gene Therapy.

[36]  C. Hart,et al.  Immunolocalization of platelet‐derived growth factor A and B chains and PDGF‐α and β receptors in human gingival wounds , 1997 .

[37]  S. Lynch,et al.  Recombinant human platelet-derived growth factor: biology and clinical applications. , 2008, The Journal of bone and joint surgery. American volume.

[38]  William V Giannobile,et al.  Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  Steven A. Goldstein,et al.  PDGF-B Gene Therapy Accelerates Bone Engineering and Oral Implant Osseointegration , 2009, Gene Therapy.